Cancer Therapeutics, Inc.'s Partner NanoTherapies, Inc. Utilizes Revolutionary Solution for Disrupting and Treating Cancer

Press Release Source: Cancer Therapeutics Cancer Therapeutics, Inc.'s Partner NanoTherapies, Inc. Utilizes Revolutionary Solution for Disrupting and Treating Cancer Calcium Phosphate Nanoparticles Key to Company's Success On Wednesday June 10, 2009, 5:23 pm EDT SALT LAKE CITY, UT--(MARKET WIRE)--Jun 10, 2009 -- Cancer Therapeutics, Inc. (OTC BB:CTHP.OB), an emerging biotechnology business incubator with a specific emphasis on disruptive cancer treatments and nanotechnology, announced recently its new partner, NanoTherapies, Inc., is utilizing calcium phosphate nanop
Read article...

Cancer Therapeutics Announces Formation of Advisory Board

Press Release Source: Cancer Therapeutics Cancer Therapeutics Announces Formation of Advisory Board Board of Advisors to Consult With Cancer Therapeutics CEO and Its Executives On Monday June 8, 2009, 7:34 pm EDT SALT LAKE CITY, UT--(MARKET WIRE)--Jun 8, 2009 -- Cancer Therapeutics, Inc. (OTC BB:CTHP.OB), an emerging biotechnology business incubator with a specific emphasis on disruptive cancer treatments and nanotechnology, announced recently the formation of an advisory board which will work closely with executive management to provide expertise and strategic guid
Read article...

Cancer Therapeutics Finalizes Definitive Agreement With NanoTherapies, LLC

Press Release Source: Cancer Therapeutics, Inc. Cancer Therapeutics Finalizes Definitive Agreement With NanoTherapies, LLC On Thursday May 28, 2009, 4:05 pm EDT SALT LAKE CITY, UT--(MARKET WIRE)--May 28, 2009 -- Cancer Therapeutics, Inc. (OTC BB:CTHP.OB), an emerging biotechnology business incubator with a specific emphasis on disruptive cancer treatments and nanotechnology, announced recently it has completed a formal agreement to acquire a minority ownership share of NanoTherapies, LLC. Finalization of the agreement comes after signing a Letter of Intent as reported in a p
Read article...

Cancer Therapeutics Signs Letter of Intent to Purchase Stake in NanoTherapies, LLC.

Press Release Source: Cancer Therapeutics Cancer Therapeutics Signs Letter of Intent to Purchase Stake in NanoTherapies, LLC. Company Will Retain 25% Ownership in Cutting Edge Cancer Treatment Company Which Utilizes Nanotechnology On Tuesday May 12, 2009, 9:30 am EDT SALT LAKE CITY, UT--(MARKET WIRE)--May 12, 2009 -- Cancer Therapeutics, Inc. (OTC BB:CTHP.OB), an emerging biotechnology business incubator with a specific emphasis on disruptive cancer treatments and nanotechnology, announced recently it has signed a letter of intent to acquire a minority ownership sha
Read article...

Cancer Therapeutics Retains The Cervelle Group to Spearhead Its Communication Program

Press Release Source: Cancer Therapeutics, Inc. Cancer Therapeutics Retains The Cervelle Group to Spearhead Its Communication Program On Wednesday May 6, 2009, 6:37 pm EDT SALT LAKE CITY, UT--(MARKET WIRE)--May 6, 2009 -- Cancer Therapeutics, Inc. (OTC BB:CTHP.OB), an emerging biotechnology business incubator with a specific emphasis on disruptive cancer treatments, announced recently the company has retained The Cervelle Group, a nationally known investor relations and public relations firm to manage the company's communications program with shareholders and the media. Canc
Read article...